A Prospective, Clinical Investigation of the Vanguard 360 Revision Knee
← catalyst calendarNCT01542580 · readout ≤ 1,960 d
Sponsored by Zimmer Biomet (industry) · ZBH — their whole pipeline →.
Phase
—
Status
Active, not recruiting
Study type
Observational
Enrollment
255estimated
Sites
12
Countries
Belgium, Denmark, France +5
Every value on this page is a field the sponsor filed with ClinicalTrials.gov, reproduced. Dates are their own estimates, revised as a study runs, unless the registry marks them actual. sources →
Source: ClinicalTrials.gov, retrieved 2026-08-19
Dates
each axis at the precision it was filed, with the registry's own basis| Date | Filed | Basis | What it is |
|---|---|---|---|
| Start | Mar 2012 | actual | When the study began enrolling |
| Primary completion | Dec 2031 | estimated | The date the last participant is measured for the primary outcome — the readout window |
| Study completion | Dec 2031 | estimated | The whole study's end, after follow-up |
| First posted | 2012-03-02 | estimated | When this record first appeared on the registry |
| Results posted | — | When the sponsor posted results to the registry | |
| Record updated | 2025-11-25 | actual | The sponsor's own last edit to this record — every projection above is as current as this date |
What it studies
Conditions
- Osteoarthritis
- Rheumatoid Arthritis
- Traumatic Arthritis
- Post Traumatic Deformity
- Complications; Arthroplasty
- Deformity of Limb
Interventions
- Device: Vanguard SSK 360 with PS Bearing
- Device: Vanguard SSK 360 with PSC bearing
- Device: Vanguard DA 360
- Device: Vanguard 360 TiNbN Femur with PS bearing
- Device: Vanguard 360 TiNbN Femur with PSC bearing
Primary outcome
what the primary-completion date above is the date OFAMERICAN KNEE SOCIETY KNEE SCORE
measured 24 months postoperative
Permalink · ZBH's whole pipeline · Catalyst calendar · Every registered study · What changed